Endpoints News Dec 3, 2025 FDA to name Tracy Beth Høeg, who helped lead Covid-shot investigation, to head CDER
Endpoints News Dec 3, 2025 Former FDA commissioners slam Prasad's plan for 'sweeping' vaccine changes
Thermo Fisher Dec 3, 2025 Thermo Fisher Scientific Insider Sold Shares Worth $8,154,131, According to a Recent SEC Filing - MarketScreener
Agilent Dec 3, 2025 Agilent Technologies (NYSE: A) director reports sale of 2,600 shares - Stock Titan
Illumina Dec 3, 2025 Illumina, Other Genomics Firms Ramp Up Data Offerings for Pharma, With Eyes on AI - GenomeWeb
FierceBiotech Dec 3, 2025 Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy
Endpoints News Dec 3, 2025 FDA seeks to raise user fees for companies running Phase 1 trials outside the US
Lonza News Dec 3, 2025 Biologics CDMO Market Trends and Investment Forecast to 2033: Features Analysis of Lonza Group, Cata - PharmiWeb.com
Lonza News Dec 3, 2025 Lonza Group (OTCMKTS:LZAGY) Sees Strong Trading Volume - Time to Buy? - MarketBeat
Endpoints News Dec 3, 2025 FDA says it won't release details of claimed Covid vaccine deaths in 'near term'
BioPharma Dive Dec 3, 2025 After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis
Endpoints News Dec 3, 2025 With Phase 3 Duchenne success, Capricor plots path forward after FDA rejection